AMRIC Vaccine

By: Nick Liard

The provincial government is investing 250 thousand dollars into a vaccine to be developed locally that with combat a bacteria that can cause stomach cancer.

Lilly Creek Vaccines Inc., a subsidiary of Health Science’s North’s Advanced Medical Research Institute of Canada will develop and test a vaccine that will fight bacterium H. pylori, a bacteria live in the digestive tract that can lead to ulcers, gastritus and stomach cancer.

Dr. Francisco Diaz-Mitoma says each investment into AMRIC is an investment into the city.

Dr. Diaz-Mitoma says AMRIC is about two years away from phase one of clinical trials, after that the vaccine would need an investment in the millions of dollars.